Betadine Export Market Intelligence: India's 92 Suppliers Shipping to 68 Countries — TransData Nexus 2026

Q: Who are the top betadine exporters from India?

The top betadine exporters from India are: 1. WIN-MEDICARE PRIVATE LIMITED — $3.8M (50.9% market share); 2. MAPAEX CONSUMER HEALTHCARE PRIVATE LIMITED — $2.2M (29.2% market share); 3. MODI-MUNDIPHARMA PRIVATE LIMITED — $394.6K (5.2% market share); 4. WIN MEDICARE PRIVATE LIMITED — $380.3K (5.0% market share); 5. MAKSON HEALTH CARE PRIVATE LIMITED — $246.6K (3.3% market share). Together they account for 93.6% of India's total betadine export value.

Q: What is the total export value of betadine from India?

The total export value of betadine from India is $7.5M USD, recorded across 1,830 shipment transactions from 92 active exporters to 68 destination countries. The average shipment value is $4.1K.

Q: Which countries import betadine from India?

India exports betadine to 68 countries worldwide. The top importing countries are: NEPAL (28.6% share, $2.2M), SRI LANKA (24.5% share, $1.8M), AUSTRALIA (19.0% share, $1.4M), KENYA (5.7% share, $429.4K), PHILIPPINES (4.8% share, $363.1K). These five markets account for 82.6% of total export value.

Q: What is the HS code for betadine exports from India?

The primary HS code for betadine exports from India is 30049087. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of betadine exports from India?

The average unit price for betadine exports from India is $2.68 USD per unit, with prices ranging from $0.02 to $255.46 depending on formulation, packaging, and order volume. The total market is valued at $7.5M across 1,830 shipments.

Q: Which ports handle betadine exports from India?

The primary ports for betadine exports from India are RAXAUL (INRXLB) (10.7% of shipments), SAHAR AIR CARGO ACC (INBOM4) (8.9% of shipments), TUGLAKABAD ICD (INTKD6) (7.9% of shipments), RAXAUL (7.9% of shipments), SAHAR AIR (7.7% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of betadine?

India is one of the world's leading exporters of betadine due to its large base of 92 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports betadine to 68 countries, demonstrating 35% global market coverage.

Q: What certifications do Indian betadine exporters need?

Indian betadine exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import betadine from India?

There are 233 registered buyers importing betadine from India, spread across 68 countries. The repeat buyer rate is 69.5%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top betadine supplier from India?

WIN-MEDICARE PRIVATE LIMITED is the leading betadine exporter from India with a market share of 50.9% and total export value of $3.8M across 626 shipments. The top 5 suppliers together control 93.6% of total export value.

Suresh Sormare

Betadine

India Pharmaceutical Trade Intelligence

$7.5M92 Suppliers68 CountriesHS 30049087

ExportsIndia → NEPAL28.6%India → SRI LANKA24.5%

Betadine Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Betadine to the World

Between 2022 and 2026, India exported $7.5M worth of betadine across 1,830 verified shipments to 68 countries — covering 35% of world markets in the Brand Names & OTC Products segment. The largest destination is NEPAL (28.6%). WIN-MEDICARE PRIVATE LIMITED leads with a 50.9% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Betadine export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Betadine export data snapshot — $7.5M · 92 exporters · 68 countriesTransData Nexus · Indian Customs Data

Top Betadine Exporters from India

92 active exporters · Ranked by export value

View all 92 →

Top Betadine Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	WIN-MEDICARE PRIVATE LIMITED	$3.8M	626	3	50.9%
2	MAPAEX CONSUMER HEALTHCARE PRIVATE LIMITED

Top Countries Importing Betadine from India

68 destination markets · Ranked by import value

All 68 countries →

Top Countries Importing Betadine from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	NEPAL	$2.2M	28.6%
2	SRI LANKA	$1.8M	24.5%
3	AUSTRALIA	$1.4M	19.0%
4	KENYA	$429.4K	5.7%
5	PHILIPPINES	$363.1K	4.8%
6	MALDIVES	$335.2K	4.4%
7	INDONESIA	$330.0K	4.4%
8	UNITED ARAB EMIRATES	$181.2K	2.4%
9	SEYCHELLES	$133.5K	1.8%
10	QATAR	$115.4K	1.5%

NEPAL is India's largest betadine export destination, absorbing 28.6% of total exports worth $2.2M. The top 5 importing countries — NEPAL, SRI LANKA, AUSTRALIA, KENYA, PHILIPPINES — together account for 82.6% of India's total betadine export value. The remaining 63 destination countries collectively receive the other 17.4%, indicating a broadly diversified export footprint across multiple regions.

Regulatory Landscape — Betadine

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, Betadine products are regulated by the Food and Drug Administration (FDA). As of March 2026, there are no specific import alerts related to Betadine or povidone-iodine products from India. However, the FDA maintains import alerts for various products, including drugs and cosmetics, to ensure compliance with U.S. regulations. For instance, Import Alert 53-21, updated in March 2026, addresses the detention without physical examination of adulterated cosmetic products and ingredients. While this alert does not specifically mention Betadine, it underscores the FDA's vigilance in monitoring imported products for compliance.

Given the absence of specific import alerts for Betadine, Indian exporters must ensure that their products comply with FDA regulations to facilitate smooth entry into the U.S. market. This includes adhering to Good Manufacturing Practices (GMP) and ensuring that all products meet the required safety and efficacy standards.

2EU & UK Regulatory Framework

In the European Union (EU) and the United Kingdom (UK), Betadine products require marketing authorization before they can be sold. The European Medicines Agency (EMA) oversees the authorization process within the EU, while the Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for the UK. Applicants must demonstrate compliance with EU Good Manufacturing Practice (GMP) requirements, which ensure that products are consistently produced and controlled according to quality standards. This involves a thorough evaluation of the product's safety, efficacy, and quality.

As of March 2026, there have been no recent regulatory actions or updates from the EMA or MHRA specifically concerning Betadine products. However, manufacturers and exporters should remain vigilant and ensure ongoing compliance with all applicable regulations to maintain market access.

3WHO Essential Medicines & Global Standards

Povidone-iodine, the active ingredient in Betadine, is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its importance in healthcare. The inclusion in the WHO Model List indicates that povidone-iodine is considered essential for addressing key health needs. Additionally, povidone-iodine formulations are recognized in various pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring standardized quality and efficacy across different regions.

4India Regulatory Classification

In India, Betadine products are classified under Schedule H of the Drugs and Cosmetics Act, indicating that they are prescription drugs and must be sold by retail only on the prescription of a registered medical practitioner. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines under the Drug Price Control Order (DPCO). As of March 2026, povidone-iodine formulations are subject to price control, with the latest ceiling price notification issued in January 2026. For exports, manufacturers must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT), ensuring that the products meet the necessary quality standards and are not in short supply domestically.

5Patent & Exclusivity Status

The primary patents for povidone-iodine formulations have expired, allowing for generic competition in the market. This has led to a diverse range of manufacturers producing Betadine equivalents, contributing to competitive pricing and widespread availability.

6Recent Industry Developments

In January 2026, the NPPA revised the ceiling prices for povidone-iodine formulations, reflecting changes in production costs and market dynamics. This adjustment aims to ensure affordability while maintaining quality standards.

In February 2026, the CDSCO issued new guidelines for the export of pharmaceutical products, emphasizing the need for stringent quality control measures and compliance with international standards. This move is intended to bolster the reputation of Indian pharmaceutical exports and ensure patient safety globally.

In March 2026, the WHO updated its Model List of Essential Medicines, reaffirming the inclusion of povidone-iodine as a critical antiseptic agent. This underscores the ongoing global recognition of its importance in healthcare settings.

These developments highlight the dynamic nature of the pharmaceutical regulatory landscape and the importance of continuous monitoring to ensure compliance and market competitiveness.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Supply Chain Risk Assessment — Betadine

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including the production of Betadine, heavily relies on Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs) imported from China. Approximately 70% of India's APIs are sourced from China, underscoring a significant dependency on Chinese suppliers. This reliance exposes the supply chain to vulnerabilities, particularly when disruptions occur in Chinese manufacturing or logistics.

Recent events have highlighted these risks. In February 2025, the FDA issued warning letters to API manufacturers in China and India for significant deviations from current Good Manufacturing Practice (cGMP), raising concerns about the quality and reliability of these critical components. Such incidents can lead to supply shortages and increased costs, affecting the availability of products like Betadine in international markets.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates a high supplier concentration for Betadine exports from India. The top five exporters account for 93.6% of the total export value, with WIN-MEDICARE PRIVATE LIMITED alone contributing 50.9%. This concentration poses a significant single-source risk; any operational or financial issues within these key suppliers could disrupt the entire supply chain.

To mitigate such risks, the Indian government has implemented the Production Linked Incentive (PLI) scheme aimed at boosting domestic API and KSM production. In October 2024, two greenfield plants were inaugurated under this scheme to manufacture critical molecules like Penicillin G and 6-APA, essential for antibiotics. While these initiatives are steps toward reducing import dependence, their impact on diversifying the supplier base for Betadine remains to be fully realized.

Access Complete Betadine Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 1,830 transactions across 68 markets.

Request Demo View Pricing

Frequently Asked Questions — Betadine Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top betadine exporters from India?

The leading betadine exporters from India are WIN-MEDICARE PRIVATE LIMITED, MAPAEX CONSUMER HEALTHCARE PRIVATE LIMITED, MODI-MUNDIPHARMA PRIVATE LIMITED, and 10 others. WIN-MEDICARE PRIVATE LIMITED leads with 50.9% market share ($3.8M). The top 5 suppliers together control 93.6% of total export value.

What is the total export value of betadine from India?

The total export value of betadine from India is $7.5M, recorded across 1,830 shipments from 92 active exporters to 68 countries. The average shipment value is $4.1K.

Which countries import betadine from India?

India exports betadine to 68 countries. The top importing countries are NEPAL (28.6%), SRI LANKA (24.5%), AUSTRALIA (19.0%), KENYA (5.7%), PHILIPPINES (4.8%), which together account for 82.6% of total export value.

What is the HS code for betadine exports from India?

The primary HS code for betadine exports from India is 30049087. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Betadine

Betadine

How India Exports Betadine to the World

Top Betadine Exporters from India

Top Countries Importing Betadine from India

Quick Facts

Related Brand Names & OTC Products

Related Analysis

Need Details?

Regulatory Landscape — Betadine

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Supply Chain Risk Assessment — Betadine

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Betadine Trade Intelligence

Frequently Asked Questions — Betadine Exports from India

Who are the top betadine exporters from India?

What is the total export value of betadine from India?

Which countries import betadine from India?

What is the HS code for betadine exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of betadine exports from India?

Which ports handle betadine exports from India?

Why is India a leading exporter of betadine?

What certifications do Indian betadine exporters need?

How many buyers import betadine from India?

What is the market share of the top betadine exporter from India?

Analysis Methodology